1. Sky‑high unit prices. Many suppliers quote > $250 / g for GMP‑grade Leuprorelin, inflating your formulation cost and eroding margins.
2. Inconsistent purity. Batch‑to‑batch variance (≥ 95 % vs. 98 % purity) forces re‑validation, adds QC workload, and risks regulatory non‑compliance.
3. Lengthy lead times. Typical 6‑8 weeks from order to delivery disrupts production schedules, especially for time‑critical oncology trials.
4. Unreliable shipping. Freight delays and customs holds increase inventory holding costs by an average of 37 % for US importers.
5. Limited customization. OEM/ODM capabilities are often absent, leaving you to source multiple vendors for peptide design, labeling, and packaging.
6. Regulatory ambiguity. Lack of clear documentation (DMF, FDA‑registered facilities) creates audit red‑flags.
These pain points translate directly into lost market share, delayed product launches, and higher R&D spend.
| Parameter | Specification |
|---|---|
| CAS Number | 51776‑33‑1 |
| Chemical Name | Leuprorelin (Luteinizing‑Hormone‑Releasing Hormone Agonist) |
| Purity (HPLC) | ≥ 99.5 % (certified) |
| Form | White to off‑white powder |
| Molecular Weight | 1209.4 g mol⁻¹ |
| Solubility | Soluble in water, DMSO, and 0.1 M HCl |
| Stability | 24 months at 25 °C (±2 °C), 60 % RH |
| Packaging Options | 25 kg bulk bag, 1 kg HDPE drum, 100 g glass vials |
| Regulatory Status | FDA‑registered, EMA‑compliant, GMP, ISO 9001 |
Oncology Clinical Trials – 2024 Phase II Study. A US biotech partnered with Global Technology for 2 kg of 99.5 % Leuprorelin. Delivery in 18 days enabled trial enrollment to stay on schedule, saving $120,000 in overtime labor.
Hormone‑Dependent Cancer Therapeutics – Manufacturing Scale‑Up. A mid‑size pharma switched from a $260 / g supplier to our $185 / g pricing, reducing API cost by 28 % and freeing capital for additional product lines.
Custom Peptide Library – Academic Research. Over 30 custom sequences were delivered under a single ODM contract, with a 99.8 % purity average, eliminating repeat‑synthesis expenses.
CAS-50-28-2-17-beta-Estradiol Acetohexamide CAS-2170181-52-7-Retatrutide CAS-38243-03-7-Sissotrin
The standard MOQ is 5 kg (≈ 4 500 g of API). For OEM projects we can accept 2 kg with a 5 % surcharge.

Yes. Every shipment includes a full DMF dossier, GMP batch record, and a Certificate of Analysis (CoA) signed by our QA director.
Our ODM team can synthesize modified Leuprorelin analogues (e.g., PEGylated, acetylated) with a lead time of 4‑6 weeks.
We provide DDP (Delivered Duty Paid) to any US port, air‑freight (48 h), or sea‑freight with real‑time tracking. Customs clearance is handled by our local agents.
Dedicated account manager, 24/7 email support, free stability data for up to 12 months, and a 30‑day money‑back guarantee if purity < 99.5 %.
Limited‑time Offer: First 10 orders receive FREE 5 g sample and 30‑day, no‑risk money‑back guarantee.
All prices are FOB Zhengzhou; DDP options available upon request.
Sarah L., Senior Procurement Manager, BioGen USA – “The speed of delivery (2 weeks) let us meet our IND filing deadline. Quality was spot‑on – no re‑testing needed.”
James K., Operations Lead, OncologyRx – “Cost reduction of $75 / g translated into a $150k savings for our 2‑kg batch. The OEM drum label matched our internal SOP perfectly.”
Linda M., C‑Level, HormoneTech – “Regulatory audit passed without any comments thanks to the complete DMF and GMP certificates supplied.”
Global Technology Co., Ltd – No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.
Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Visit our Contact Page for a personalized quote, NDA, or factory tour.
© 2026 Global Technology Co., Ltd – All Rights Reserved. Privacy Policy | Terms of Service
Social Proof – Trusted by Industry Leaders Worldwide
Customer Logo Wall
Testimonials with Measurable Results
Certificates & Compliance (Red/Blue/Underline Highlights)
CE, FDA, GMP, ISO 9001, DMF, RoHS, CB, VDE. All certificates are downloadable on request.